Cargando…
Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study
(1) Background: Sepsis is a leading cause of death and a global public health problem. Accordingly, deciphering the underlying molecular mechanisms of this disease and the determinants of its morbidity and mortality is pivotal. This study examined the effect of the rs951818 SNP of the negative costi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621793/ https://www.ncbi.nlm.nih.gov/pubmed/34830585 http://dx.doi.org/10.3390/jcm10225302 |
_version_ | 1784605541034622976 |
---|---|
author | Mewes, Caspar Alexander, Tessa Büttner, Benedikt Hinz, José Alpert, Ayelet Popov, Aron-F. Beißbarth, Tim Tzvetkov, Mladen Grade, Marian Quintel, Michael Bergmann, Ingo Mansur, Ashham |
author_facet | Mewes, Caspar Alexander, Tessa Büttner, Benedikt Hinz, José Alpert, Ayelet Popov, Aron-F. Beißbarth, Tim Tzvetkov, Mladen Grade, Marian Quintel, Michael Bergmann, Ingo Mansur, Ashham |
author_sort | Mewes, Caspar |
collection | PubMed |
description | (1) Background: Sepsis is a leading cause of death and a global public health problem. Accordingly, deciphering the underlying molecular mechanisms of this disease and the determinants of its morbidity and mortality is pivotal. This study examined the effect of the rs951818 SNP of the negative costimulatory lymphocyte-activation gene 3 (LAG-3) on sepsis mortality and disease severity. (2) Methods: 707 consecutive patients with sepsis were prospectively enrolled into the present study from three surgical ICUs at University Medical Center Goettingen. Both 28- and 90-day mortality were analyzed as the primary outcome, while parameters of disease severity served as secondary endpoints. (3) Results: In the Kaplan–Meier analysis LAG-3 rs951818 AA-homozygote patients showed a significantly lower 28-day mortality (17.3%) compared to carriers of the C-allele (23.7%, p = 0.0476). In addition, these patients more often received invasive mechanical ventilation (96%) during the course of disease than C-allele carriers (92%, p = 0.0466). (4) Conclusions: Genetic profiling of LAG-3 genetic variants alone or in combination with other genetic biomarkers may represent a promising approach for risk stratification of patients with sepsis. Patient-individual therapeutic targeting of immune checkpoints, such as LAG-3, may be a future component of sepsis therapy. Further detailed investigations in clinically relevant sepsis models are necessary. |
format | Online Article Text |
id | pubmed-8621793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86217932021-11-27 Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study Mewes, Caspar Alexander, Tessa Büttner, Benedikt Hinz, José Alpert, Ayelet Popov, Aron-F. Beißbarth, Tim Tzvetkov, Mladen Grade, Marian Quintel, Michael Bergmann, Ingo Mansur, Ashham J Clin Med Article (1) Background: Sepsis is a leading cause of death and a global public health problem. Accordingly, deciphering the underlying molecular mechanisms of this disease and the determinants of its morbidity and mortality is pivotal. This study examined the effect of the rs951818 SNP of the negative costimulatory lymphocyte-activation gene 3 (LAG-3) on sepsis mortality and disease severity. (2) Methods: 707 consecutive patients with sepsis were prospectively enrolled into the present study from three surgical ICUs at University Medical Center Goettingen. Both 28- and 90-day mortality were analyzed as the primary outcome, while parameters of disease severity served as secondary endpoints. (3) Results: In the Kaplan–Meier analysis LAG-3 rs951818 AA-homozygote patients showed a significantly lower 28-day mortality (17.3%) compared to carriers of the C-allele (23.7%, p = 0.0476). In addition, these patients more often received invasive mechanical ventilation (96%) during the course of disease than C-allele carriers (92%, p = 0.0466). (4) Conclusions: Genetic profiling of LAG-3 genetic variants alone or in combination with other genetic biomarkers may represent a promising approach for risk stratification of patients with sepsis. Patient-individual therapeutic targeting of immune checkpoints, such as LAG-3, may be a future component of sepsis therapy. Further detailed investigations in clinically relevant sepsis models are necessary. MDPI 2021-11-15 /pmc/articles/PMC8621793/ /pubmed/34830585 http://dx.doi.org/10.3390/jcm10225302 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mewes, Caspar Alexander, Tessa Büttner, Benedikt Hinz, José Alpert, Ayelet Popov, Aron-F. Beißbarth, Tim Tzvetkov, Mladen Grade, Marian Quintel, Michael Bergmann, Ingo Mansur, Ashham Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title | Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title_full | Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title_fullStr | Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title_full_unstemmed | Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title_short | Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study |
title_sort | effect of the lymphocyte activation gene 3 polymorphism rs951818 on mortality and disease progression in patients with sepsis—a prospective genetic association study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621793/ https://www.ncbi.nlm.nih.gov/pubmed/34830585 http://dx.doi.org/10.3390/jcm10225302 |
work_keys_str_mv | AT mewescaspar effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT alexandertessa effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT buttnerbenedikt effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT hinzjose effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT alpertayelet effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT popovaronf effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT beißbarthtim effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT tzvetkovmladen effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT grademarian effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT quintelmichael effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT bergmanningo effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy AT mansurashham effectofthelymphocyteactivationgene3polymorphismrs951818onmortalityanddiseaseprogressioninpatientswithsepsisaprospectivegeneticassociationstudy |